186 related articles for article (PubMed ID: 32728703)
1. Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK.
Mbisa JL; Ledesma J; Kirwan P; Bibby DF; Manso C; Skingsley A; Murphy G; Brown A; Dunn DT; Delpech V; Geretti AM
J Antimicrob Chemother; 2020 Nov; 75(11):3311-3318. PubMed ID: 32728703
[TBL] [Abstract][Full Text] [Related]
2. Primary resistance to integrase strand transfer inhibitors in Spain using ultrasensitive HIV-1 genotyping.
Casadellà M; Santos JR; Noguera-Julian M; Micán-Rivera R; Domingo P; Antela A; Portilla J; Sanz J; Montero-Alonso M; Navarro J; Masiá M; Valcarce-Pardeiro N; Ocampo A; Pérez-Martínez L; Pasquau J; Vivancos MJ; Imaz A; Carmona-Oyaga P; Muñoz-Medina L; Villar-García J; Barrufet P; Paredes R;
J Antimicrob Chemother; 2020 Dec; 75(12):3517-3524. PubMed ID: 32929472
[TBL] [Abstract][Full Text] [Related]
3. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
Tzou PL; Rhee SY; Descamps D; Clutter DS; Hare B; Mor O; Grude M; Parkin N; Jordan MR; Bertagnolio S; Schapiro JM; Harrigan PR; Geretti AM; Marcelin AG; Shafer RW;
J Antimicrob Chemother; 2020 Jan; 75(1):170-182. PubMed ID: 31617907
[TBL] [Abstract][Full Text] [Related]
4. Primary resistance to integrase strand-transfer inhibitors in Europe.
Casadellà M; van Ham PM; Noguera-Julian M; van Kessel A; Pou C; Hofstra LM; Santos JR; Garcia F; Struck D; Alexiev I; Bakken Kran AM; Hoepelman AI; Kostrikis LG; Somogyi S; Liitsola K; Linka M; Nielsen C; Otelea D; Paraskevis D; Poljak M; Puchhammer-Stöckl E; Staneková D; Stanojevic M; Van Laethem K; Zidovec Lepej S; Clotet B; Boucher CA; Paredes R; Wensing AM;
J Antimicrob Chemother; 2015 Oct; 70(10):2885-8. PubMed ID: 26188038
[TBL] [Abstract][Full Text] [Related]
5. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
Karade S; Sen S; Sashindran VK
AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
[TBL] [Abstract][Full Text] [Related]
6. Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013.
Stekler JD; McKernan J; Milne R; Tapia KA; Mykhalchenko K; Holte S; Maenza J; Stevens CE; Buskin SE; Mullins JI; Frenkel LM; Collier AC
Antivir Ther; 2015; 20(1):77-80. PubMed ID: 24831260
[TBL] [Abstract][Full Text] [Related]
7. HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention.
Eshleman SH; Fogel JM; Halvas EK; Piwowar-Manning E; Marzinke MA; Kofron R; Wang Z; Mellors J; McCauley M; Rinehart AR; St Clair M; Adeyeye A; Hinojosa JC; Cabello R; Middelkoop K; Hanscom B; Cohen MS; Grinsztejn B; Landovitz RJ;
J Infect Dis; 2022 Dec; 226(12):2170-2180. PubMed ID: 36240386
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Integrase Strand Transfer Inhibitors Resistance Mutations in Integrase Strand Transfer Inhibitors-Naive and -Experienced HIV-1 Infected Patients: A Single Center Experience.
De Francesco MA; Izzo I; Properzi M; Gargiulo F; Caccuri F; Quiros-Roldan E; Castelli F; Caruso A; Focà E
AIDS Res Hum Retroviruses; 2018 Jul; 34(7):570-574. PubMed ID: 29631420
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and analysis of acquired and transmitted integrase strand transfer inhibitor-associated HIV-1 drug resistance in Chongqing, China.
Zhang H; Wu P; Li J; Li M
Virulence; 2023 Dec; 14(1):2278254. PubMed ID: 37941373
[TBL] [Abstract][Full Text] [Related]
11. Integrase Strand Transfer Inhibitor Resistance Mutations in Antiretroviral Therapy-Naive and Treatment-Experienced HIV Patients in South Korea.
Jeong W; Jung IY; Choi H; Kim JH; Seong H; Ahn JY; Jeong SJ; Ku NS; Kim JM; Choi JY
AIDS Res Hum Retroviruses; 2019 Feb; 35(2):213-216. PubMed ID: 30229661
[TBL] [Abstract][Full Text] [Related]
12. Integrase Strand Transfer Inhibitor Resistance in Integrase Strand Transfer Inhibitor-Naive Persons.
Bailey AJ; Rhee SY; Shafer RW
AIDS Res Hum Retroviruses; 2021 Oct; 37(10):736-743. PubMed ID: 33683148
[TBL] [Abstract][Full Text] [Related]
13. Short Communication: Trends in Transmitted Drug Resistance in Treatment-Naive HIV Patients in Korea.
Jung EJ; Lee SH; Lee S; Lee JE; Lee SO; Park S; Kim HH; Kang JS; Woo HJ
AIDS Res Hum Retroviruses; 2020 Nov; 36(11):905-909. PubMed ID: 32791842
[TBL] [Abstract][Full Text] [Related]
14. Integrase Strand Transfer Inhibitors (INSTIs) Resistance Mutations in HIV-1 Infected Turkish Patients.
Sayan M; Gündüz A; Ersöz G; İnan A; Deveci A; Özgür G; Sargın F; Karagöz G; İnci A; İnan D; Ülçay A; Karaoğlan I; Kaya S; Kutlu SS; Süer K; Çağatay A; Akalın H
HIV Clin Trials; 2016 May; 17(3):109-13. PubMed ID: 27125365
[TBL] [Abstract][Full Text] [Related]
15. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
Henerico S; Lyimo E; Makubi AN; Magesa D; Desderius B; Mueller A; Changalucha J; Kalluvya SE; Van Zyl G; Preiser W; Mshana SE; Kasang C
J Antimicrob Chemother; 2022 Oct; 77(11):3138-3143. PubMed ID: 36101479
[TBL] [Abstract][Full Text] [Related]
16. Resistance-Associated Mutations and Polymorphisms among Integrase Inhibitor-Naïve HIV-1 Patients in Kuwait.
Chehadeh W; Albaksami O; John SE; Al-Nakib W
Intervirology; 2017; 60(4):131-137. PubMed ID: 29212076
[TBL] [Abstract][Full Text] [Related]
17. Pre-Treatment Integrase Inhibitor Resistance and Natural Polymorphisms among HIV-1 Subtype C Infected Patients in Ethiopia.
Arimide DA; Szojka ZI; Zealiyas K; Gebreegziabxier A; Adugna F; Sasinovich S; Björkman P; Medstrand P
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458459
[TBL] [Abstract][Full Text] [Related]
18. Short Communication: HIV-1 Drug Resistance Mutation Analyses of Cameroon-Derived Integrase Sequences.
Mikasi SG; Isaacs D; Ikomey GM; Shimba H; Cloete R; Jacobs GB
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):54-56. PubMed ID: 32640829
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
Wenk BM; Mbunkah HA; Nsanwe NN; Mbu ET; Besong LM; Sama BA; Orock E; Leemann C; Metzner KJ
J Antimicrob Chemother; 2021 Jan; 76(1):124-129. PubMed ID: 32954411
[TBL] [Abstract][Full Text] [Related]
20. Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
Marcelin AG; Grude M; Charpentier C; Bellecave P; Le Guen L; Pallier C; Raymond S; Mirand A; Bocket L; Fofana DB; Delaugerre C; Nguyen T; Montès B; Jeulin H; Mourez T; Fafi-Kremer S; Amiel C; Roussel C; Dina J; Trabaud MA; Le Guillou-Guillemette H; Vallet S; Signori-Schmuck A; Maillard A; Ferre V; Descamps D; Calvez V; Flandre P;
J Antimicrob Chemother; 2019 May; 74(5):1368-1375. PubMed ID: 30789205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]